5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 28.50▲ | 28.55▲ | 28.83▼ | 31.61▼ | 31.08▼ |
MA10 | 28.45▲ | 28.84▼ | 28.44▲ | 32.11▼ | 31.30▼ |
MA20 | 28.48▲ | 28.41▲ | 29.87▼ | 32.76▼ | 31.05▼ |
MA50 | 28.82▼ | 31.13▼ | 32.26▼ | 31.44▼ | 40.82▼ |
MA100 | 28.54▲ | 32.23▼ | 32.56▼ | 32.10▼ | 51.23▼ |
MA200 | 29.51▼ | 32.71▼ | 33.34▼ | 37.45▼ | 50.60▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.034▲ | 0.188▲ | 0.050▲ | -0.613▼ | 0.529▲ |
RSI | 52.254▲ | 40.901▼ | 36.106▼ | 36.393▼ | 40.255▼ |
STOCH | 56.187 | 32.636 | 62.000 | 46.975 | 59.070 |
WILL %R | -11.764▲ | -46.241 | -58.163 | -84.933▼ | -62.654 |
CCI | 136.490▲ | -26.070 | 19.103 | -202.484▼ | -49.122 |
Monday, January 13, 2025 10:08 AM
Apellis (APLS) stock jumped 8% Monday after the company announced preliminary Q4 and 2024 revenue results along with several business updates. Read more here.
|
Monday, January 13, 2025 06:27 AM
Reports $709 million in preliminary1 full-year 2024 U.S. net product revenues$611 million in SYFOVRE® U.S. net product revenues, including $167 ...
|
Friday, January 10, 2025 05:00 AM
WALTHAM, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that Keli Walbert will join the Apellis Board of Directors, effective immediately. Ms.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/01/25 | 28.58 | 29.668 | 27.63 | 28.59 | 3,671,261 |
10/01/25 | 30.00 | 30.375 | 27.35 | 27.44 | 3,958,693 |
08/01/25 | 34.30 | 34.48 | 32.96 | 33.00 | 1,621,071 |
07/01/25 | 34.715 | 35.58 | 33.855 | 34.62 | 1,341,792 |
06/01/25 | 33.68 | 35.14 | 33.36 | 34.38 | 4,122,859 |
03/01/25 | 33.24 | 34.145 | 33.155 | 33.46 | 2,742,562 |
02/01/25 | 32.32 | 33.50 | 31.87 | 33.16 | 1,219,736 |
31/12/24 | 32.10 | 32.74 | 31.43 | 31.91 | 977,704 |
30/12/24 | 32.13 | 32.50 | 31.88 | 31.90 | 3,050,175 |
27/12/24 | 32.86 | 33.33 | 32.44 | 32.68 | 942,145 |
|
|
||||
|
|
||||
|
|